MetabolicRetatrutide
5mg
Triple agonist peptide for metabolic research
€65.00In Stock
1
Purity
≥99%
Molecular Weight
4113.68 g/mol
HPLC Tested
COA Available
Fast EU Shipping
Product Description
Retatrutide (LY3437943) is a novel triple agonist research peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. This innovative peptide represents a significant advancement in metabolic research, combining the actions of three key metabolic hormones in a single molecule. It has demonstrated remarkable potential in preclinical and early clinical studies for metabolic regulation and body composition research.
Research Applications
- Triple receptor activation (GLP-1, GIP, glucagon)
- Advanced metabolic pathway research
- Body composition and weight management studies
- Glucose homeostasis and insulin sensitivity research
- Energy expenditure and appetite regulation studies
⚠️ Research Use Only: This product is intended for laboratory research purposes only. It is not approved for human consumption or medical use.